Cleared Traditional

K932109 - PROFILOMAT

K932109 is an FDA 510(k) clearance for PROFILOMAT, manufactured by Qmed, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 214-day FDA review.

K932109 · Qmed, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1993
Decision
214d
Days
Class 2
Risk

K932109 is an FDA 510(k) clearance for the PROFILOMAT. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Qmed, Inc. (Laurence Harbor, US). The FDA issued a Cleared decision on December 3, 1993 after a review of 214 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Qmed, Inc. devices

FDA 510(k) Submission Details - K932109

510(k) Number K932109 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 1993
Decision Date December 03, 1993
Days to Decision 214 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
89d slower than avg
Panel avg: 125d · This submission: 214d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 880
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K932109.
EXACTA-SPEZIAL
K925295 · Rudolf Riester GmbH & Co. KG · Mar 1994
PRECISA
K925294 · Rudolf Riester GmbH & Co. KG · Feb 1994
BATTERY PACK# S1018LA FOR IVAC 4000, 4200 VITAL CHECK
K932823 · Portable Power Systems, Inc. · Feb 1994
OSCILLOMATE BLOOD PRESSURE MONITOR-MODEL 9300
K925402 · Cas Medical Systems, Inc. · Sep 1993
CRITIKON VITAL SIGNS MODULE
K915697 · Critikon Company, LLC · Jul 1993
OMRON OSCILLOMETRIC DIGITAL BLOOD PRESSURE MONIT.
K930798 · Omron Healthcare, Inc. · May 1993